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Objective: In ‘‘true’’ parachute mitral valve, mitral valve chordae insert into one papillary muscle. In parachute-
like asymmetric mitral valve, most or all chordal attachments are to one papillary muscle. This study compared
morphologic features, associated lesions, and palliation strategies of the two parachute mitral valve and dominant
papillary muscle types and examined interventions and midterm outcomes in patients with biventricular circulation.
Methods: Echocardiography and autopsy databases were reviewed to identify patients with ‘‘true’’ parachute
mitral valve or parachute-like asymmetric mitral valve from January 1987 to January 2006. Predictors of pallia-
tion strategy in the entire cohort, mitral stenosis on initial echocardiogram, and mortality in the biventricular co-
hort were determined with logistic regression.
Results: Eighty-six patients with ‘‘true’’ parachute mitral valve (n ¼ 49) or parachute-like asymmetric mitral
valve (n ¼ 37) were identified. Chordal attachments to the posteromedial papillary muscle were more common
(73%). The presence ‘‘true’’ parachute mitral valve (P ¼ .008), hypoplastic left ventricle (P< .001), and two or
more left-sided obstructive lesions (P¼ .002) predicted univentricular palliation. Among 49 patients maintaining
biventricular circulation at follow-up, 8 died median follow-up 6.4 years (7 days–17.8 years). Multivariate anal-
ysis revealed that ‘‘true’’ parachute mitral valve was associated with mitral stenosis on initial echocardiogram
(P ¼ .03), and ‘‘true’’ parachute mitral valve (P ¼ .04) and conotruncal anomalies (P ¼ .0003) were associated
with mortality. Progressive mitral stenosis was found in 11 patients; 2 underwent mitral valve interventions, and
1 died.
Conclusion: Nearly two thirds of this parachute mitral valve cohort underwent biventricular palliation. Some
progression of mitral stenosis occurred, although mitral valve intervention was rare. ‘‘True’’ parachute mitral
valve was associated with mitral stenosis on initial echocardiogram. ‘‘True’’ parachute mitral valve and conotrun-
cal anomalies were associated with mortality in the biventricular population.Supplemental material is available online.
Congenital mitral stenosis (MS) results from a variety of an-
atomic anomalies in the pediatric population, and it is com-
monly associated with parachute mitral valve (PMV),1,2 an
abnormality in which the mitral valve (MV) chordae insert
into a single papillary muscle (anterolateral papillary muscle
[ALPM] or posteromedial papillary muscle [PMPM]).3
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ilar anomaly in which chordae are distributed unequally be-
tween two identifiable papillary muscles. Usually the
dominant papillary muscle is normal and the other is elon-
gated and displaced toward the mitral valve annulus. Al-
though both mitral valve anomalies have predominant
unifocalization of chordae, ‘‘true’’ PMV has only one pap-
illary muscle to which all chordae are attached. When both
types of PMV occur, the chordae are short and thickened,
limiting movement of normal mitral valve leaflets3 and re-
sulting in functional and hemodynamic abnormalities.5 Al-
though clinical presentations may be similar, ‘‘true’’ PMV
and PLAMV are defined separately, because the valves orig-
inate and develop in different ways morphogenetically.6
PMV is associated with other cardiac anomalies,7 which
significantly affect patient outcome.8 These associations
may determine whether a patient requires univentricular pal-
liation, in which an atrial septectomy is performed, making
the tricuspid valve the systemic atrioventricular valve and
thus rendering the functional outcome of the PMV less im-
portant. In patients with ‘‘true’’ PMV or PLAMV and a bi-
ventricular circulation, the degree of MS or mitral
regurgitation (MR) is of paramount importance.
Historically, ‘‘true’’ PMV and PLAMV have been
grouped together and analyzed as a single lesion. Theardiovascular Surgery c Volume 137, Number 2 385
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ALPM ¼ anterolateral papillary muscle
MR ¼ mitral regurgitation
MS ¼ mitral stenosis
MV ¼ mitral valve
PLAMV ¼ parachutelike asymmetric mitral valve
PMPM ¼ posteromedial papillary muscle
PMV ¼ parachute mitral valve
influence of PMV type and dominant papillary muscle on
associated lesions, palliation strategies, and outcomes in
patients who maintain a biventricular circulation has not
been previously analyzed. The objectives of this study
were as follows: (1) to describe and compare the morpho-
logic features and associated lesions of the two PMV and
dominant papillary muscle types, (2) to assess for predictors
of univentricular palliation in the entire PMV cohort, (3) to
describe the interventions and midterm outcomes of patients
who maintained biventricular circulation, and (4) to assess
for predictors of MS on initial echocardiogram, progressive
MS and MR, and mortality in the biventricular cohort.
METHODS
Study Design
This study was a retrospective case series including all patients with the
diagnosis of ‘‘true’’ PMV or PLAMV from January 1, 1987, to January 1,
2006, at The Children’s Hospital of Philadelphia. The study was approved
by the institutional review board (IRB #2006-3-4758).
Patient Data
Patients were identified through the echocardiography laboratory data-
base and Cardiac Registry via autopsy specimen at The Children’s Hospital
of Philadelphia. Demographic information, echocardiography, and surgical
and catheter-based intervention data were collected from patient charts,
echocardiography laboratory, and cardiology databases at The Children’s
Hospital of Philadelphia. Most autopsy reports identified through the Car-
diac Registry did not specify PMV type or dominant papillary muscle,
necessitating specimen examination. If disagreement was noted between
echocardiogram and autopsy specimen, autopsy data were used. Patients
were separated into univentricular and biventricular categories according
to palliation strategy. Patients with biventricular circulation who were
unavailable for follow-up were excluded from outcome analysis. Patients
with common atrioventricular canal were excluded.
Echocardiographic Data
The images from the initial echocardiogram were reviewed for papillary
muscle anatomy, original anatomic diagnoses, associated cardiac lesions,
and the presence of MS and MR. When all pertinent echocardiographic in-
formation was not present, additional echocardiograms were reviewed to
complete data acquisition.
‘‘True’’ PMV was diagnosed when a mitral valve with unifocal attach-
ment to a single papillary muscle was identified with 2-dimensional echo-
cardiography (Figure 1, A). PLAMV was diagnosed when two papillary
muscles were identified, with one papillary muscle receiving most or all
of the chordae from the mitral valve leaflets (Figure 1, B). Normal mitral
valve anatomy features bifocal attachment of chordae distributed equally386 The Journal of Thoracic and Cardiovascular Subetween two distinct papillary muscles (Figure 1, C). These definitions
are those described by Oosthoek and colleagues.4
The levels of left-sided obstruction were identified at the mitral valve
(supravalvular mitral ring, MS), aortic valve (subaortic stenosis, aortic ste-
nosis, aortic atresia, supravalvular aortic stenosis), and aortic arch (aortic
arch hypoplasia, coarctation of the aorta, interrupted aortic arch). MS was
defined as mild (mean Doppler gradient 3–5 mm Hg or peak Doppler gra-
dient 5–8 mm Hg) or moderate or greater (mean Doppler gradient>5 mm
Hg or peak Doppler gradient>8 mm Hg). Aortic stenosis was defined as
a peak instantaneous pressure gradient across the aortic valve of at least
20 mm Hg, an aortic valve annulus with a z score less than2.0, or both.
Aortic arch obstruction was defined as an adjusted peak instantaneous pres-
sure gradient of greater than 10 mm Hg or a z score less than2.0 for the
ascending, transverse, or isthmus regions of the aorta. The left ventricle
was considered hypoplastic when the length of the left ventricle was less
than 80% of the distance from the atrioventricular groove to the apex of
the heart. According to the regurgitant jet area relative to the left atrial
area, MR was defined as none, trivial or mild (<30%), moderate
(30%50%), or severe (>50%).9
Follow-up data and most recent echocardiogram were obtained for pa-
tients with a biventricular circulation. Most recent echocardiographic results
were obtained before any mitral valve intervention, if applicable. The fol-
low-up echocardiogram and data for biventricular patients no longer fol-
lowed up at our institution were obtained from each patient’s cardiologist
with permission. Presence, degree, and progression of MS and MR were as-
sessed. Progressive MS was defined as any increase in mean gradient at least
2 mm Hg, an increase in peak gradient greater than 3 mm Hg, or by an in-
crease from no MS to the presence of MS relative to the initial echocardio-
gram. Progressive MR was defined by any increase in category of
regurgitation relative to initial echocardiogram. Patients with only one echo-
cardiogram before death or mitral valve intervention were excluded from
analysis of progressive MS or MR.
Statistical Methods
Nonparametric data were expressed as median and range, and parametric
data were expressed as mean SD. Dichotomous variables were tabulated.
The Fisher exact test was used to assess for associations between PMV
type, dominant papillary muscle, and associated lesions, as well as associa-
tions between palliative strategy and PMV type, dominant papillary muscle,
associated lesions, and increasing levels of left-sided obstruction. Logistic
regression with multiple predictors and backward model selection was
then used to identify predictors of palliation strategy.
After the biventricular cohort was identified, associations between PMV
type, dominant papillary muscle, and surgical and catheter-based interven-
tions were assessed with the Fisher exact test. Logistic regression was used
to assess for predictors of MS at initial echocardiogram. Predictors of mor-
tality in the biventricular group were identified by logistic regression and
Cox proportional hazard regression analysis. Kaplan–Meier curves for
time to death were computed and plotted, and variables that showed an as-
sociation with mortality were stratified. The log-rank test was used to assess
for differences in survival between stratified groups. Multivariate analysis
was not used to predict progressive MS, because only two echocardiograms
(initial and most recent) were used for analysis, and the exact time after ini-
tial echocardiogram at which the MS progressed was not known. Echocar-
diographic changes in MS and MR were assessed with the McNemar test for
correlated proportions. Statistical analysis was performed with R version
2.2.0 (http://www.r-project.org) and STATA 10.0 (StataCorp LP, College
Station, Tex).
A sequential Bonferroni correction (Holm method) was used to correct
for multiple comparisons.10 A P value at least .025 but less than .05 was
considered to represent a trend toward significance when multiple compar-
isons were performed. A P value at least .05 but less than .10 was considered
a trend toward significance when performing the McNemar test for corre-
lated proportions.rgery c February 2009
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DFIGURE 1. Mitral valve anatomy. Schematic drawings of true parachute mitral valve, with all chordae attached to a single papillary muscle (A); parachute-
like asymmetric mitral valve, with chordae attached to two papillary muscles, one being elongated and displaced toward mitral valve annulus (B); and normal
mitral valve, with chordae distributed equally between two distinct papillary muscles (C). Reproduced with permission from: Oosthoek PW, Wenink
AC, Macedo AJ, Gittenberger-de Groot AC. The parachute-like asymmetric mitral valve and its two papillary muscles. J Thorac Cardiovasc Surg.
1997;114:9-15.RESULTS
Patient Population
A total of 86 patients with ‘‘true’’ PMV (n ¼ 49) or
PLAMV (n ¼ 37) were identified. Eighty-one patients
were identified in the echocardiography database, and 5 ad-
ditional patients were identified solely in the Cardiac Regis-
try from autopsy reports; all of the latter had univentricular
circulation. The patients identified solely in the Cardiac Reg-
istry all predated the echocardiography database, and echo-
cardiogram reports were not available for review. Most of
the patients (n ¼ 54, 63%) were male, and the median age
at initial echocardiogram was 11 days (range 1 day–16.8
years). In 86% of the patients, the initial echocardiogram re-
vealed all the echocardiographic data points, whereas 8% re-
quired evaluation of a second echocardiogram. Six percent
of the cohort had anatomic details obtained from autopsy
specimen inspection. Chordal attachments were more com-
mon to the PMPM (n ¼ 63, 73%). One or more associated
cardiac lesions were found in 85 of 86 patients and are listed
in Table 1. Sixty-two patients (72%) in the cohort had at
least one level of left-sided obstruction, 40 patients (47%)
had two or more levels of left-sided obstruction, and 18 pa-
tients (21%) had three or more levels of left-sided obstruc-
tion. Eleven patients (12%) had conotruncal anomalies
(interrupted aortic arch, tetralogy of Fallot, double-outlet
right ventricle, dextrotransposition of the great arteries)
and had right and/or left-sided obstructive lesions. Associ-
ated genetic defects, noncardiac anomalies, or syndromes
were found in 13 patients (15%) and are described in TableThe Journal of Thoracic and CE1; the most commonly identified noncardiac abnormality
was 22q11 microdeletion (n ¼ 4, 4.7%).
A comparison of patient demographic characteristics and
associated cardiac lesions by PMV type and dominant pap-
illary muscle is shown in Table 1. For both types of PMV,
PMPM was the dominant papillary muscle (n ¼ 36 in
‘‘true’’ PMV, 73%, n ¼ 27 in PLAMV, 73%). There
were no statistically significant associations noted among
PMV type, dominant papillary muscle, associated cardiac
lesions, and levels of left-sided obstruction.
Management
Three patients in the cohort (3.5%) did not undergo any
surgical or catheter-based intervention and proceeded
down a biventricular management pathway. Biventricular
palliation was pursued in 58.1% of the patients (n ¼ 50),
and univentricular palliation was undertaken in 38.4%
(n¼ 33). Patient demographic characteristics and associated
cardiac lesions by palliation strategy are noted in Table 2.
There was an association between an increasing number of
levels of left-sided obstruction and univentricular palliation
(P<.001). When stratifying by number of levels of obstruc-
tion, the presence of two or more levels of left-sided obstruc-
tion was strongly associated with univentricular palliation
(P < .001). One level of left-sided obstruction was not
statistically significantly associated with univentricular pal-
liation.
Multivariate analysis of lesions associated with univen-
tricular palliation revealed ‘‘true’’ PMV (P ¼ .008), theardiovascular Surgery c Volume 137, Number 2 387
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PMV type Dominant papillary muscle
Total ‘‘True’’ PMV PLAMV ALPM PMPM
Total 86 49 37 23 63
Male 30 (61%) 24 (65%) 16 (70%) 38 (60%)
ALPM 13 (27%) 10 (27%)
PMPM 36 (73%) 27 (73%)
Associated lesions
Ventricular septal defect 44 (52%) 28 (57%) 16 (43%) 13 (57%) 31 (49%)
Conoventricular 18 (37%) 11 (30%) 9 (39%) 20 (32%)
Malalignment 5 (10%) 3 (8%) 3 (13%) 5 (8%)
Muscular 8 (16%) 5 (16%) 2 (9%) 11 (17%)
Inlet 1 (2%) 1 (3%) 1 (4%) 1 (2%)
Atrial septal defect 11 (13%) 9 (18%) 2 (5%) 4 (17%) 7 (11%)
Hypoplastic left ventricle 29 (34%) 19 (39%) 10 (27%) 6 (26%) 23 (37%)
Aortic stenosis 21 (24%) 12 (24%) 9 (24%) 7 (30%) 14 (22%)
Aortic atresia 4 (5%) 4 (8%) 0 1 (4%) 3 (5%)
Bicuspid aortic valve 35 (41%) 16 (33%) 19 (51%) 7 (30%) 28 (44%)
Subaortic stenosis 12 (14%) 6 (12%) 6 (16%) 4 (17%) 8 (13%)
Aortic arch hypoplasia 35 (41%) 22 (45%) 13 (35%) 7 (30%) 28 (44%)
Supravalvular mitral ring 5 (6%) 2 (4%) 3 (8%) 2 (9%) 3 (5%)
Coarctation of aorta 48 (56%) 23 (47%) 25 (68%) 12 (52%) 36 (57%)
Interrupted aortic arch 2 (2%) 1 (2%) 1 (3%) 0 2 (3%)
Tetralogy of Fallot* 6 (7%) 5 (10%) 1 (3%) 2 (9%) 4 (6%)
Double-outlet right ventricle 2 (2%) 2 (4%) 0 1 (4%) 1 (2%)
Dextrotransposition of great arteries 1 (1%) 1 (2%) 0 0 1 (2%)
Initial mitral stenosis 22 (45%) 15 (41%) 11 (48%) 26 (41%)
Left superior vena cava to coronary sinus 15 (17%) 8 (16%) 7 (19%) 5 (22%) 10 (16%)
Left-sided obstructive lesions
0 24 (28%) 15 (31%) 9 (24%) 7 (30%) 17 (27%)
1 62 (72%) 34 (69%) 28 (76%) 16 (70%) 46 (73%)
2 40 (47%) 22 (45%) 18 (49%) 10 (43%) 30 (48%)
3 18 (21%) 10 (20%) 8 (22%) 5 (22%) 13 (21%)
Values are numbers of patients with percentages of total population, parachute mitral valve type, or dominant papillary muscle with each characteristic, as applicable. There were no
statistically significant associations noted among parachute mitral valve type, dominant papillary muscle, and associated cardiac lesions. PMV, Parachute mitral valve; PLAMV,
parachutelike asymmetric mitral valve; ALPM, anterolateral papillary muscle; PMPM, posteromedial papillary muscle. *Tetralogy of Fallot alone, with absent pulmonary valve, or
with pulmonary atresia.presence of a hypoplastic left ventricle (P< .001), and two
or more levels of left-sided obstruction (P ¼ .002) as the
strongest predictors of univentricular palliation. There was
a trend toward an association between univentricular pallia-
tion and the presence of a muscular ventricular septal defect
(P ¼ .033). No lesions predicted biventricular palliation,
and there was no association between dominant papillary
muscle and palliation strategy.
Most patients with ‘‘true’’ PMV and PLAMV who under-
went univentricular palliation had a Norwood procedure per-
formed as the initial operation (n ¼ 31, 94%). Two patients
had pulmonary artery banding performed at the neonatal pal-
liation. Both of these patients later underwent a hemi-Fontan
procedure in combination with a Damus–Kaye–Stansel pro-
cedure. Initial neonatal palliation procedures for the univen-
tricular group are noted in Table 3.
Biventricular circulation was maintained in 53 of 86
patients (62%, ‘‘true’’ PMV n¼ 25, 47%, PLAMV n¼ 28,388 The Journal of Thoracic and Cardiovascular Sur53%), 38 of whom (72%) had the PMPM as the dominant
papillary muscle. Ninety-two percent of the patients with bi-
ventricular circulation (49/53) had follow-up data and were
included in analysis. Only 3 patients in the biventricular
group (6%) remained free of cardiac intervention; the re-
maining 46 patients underwent a total of 68 operations and
catheter-based interventions. Surgical and catheter-based
interventions for the biventricular cohort are delineated in
Table 3. There were no statistically significant associations
noted between PMV type, dominant papillary muscle, and
surgical and catheter-based interventions for the biventricu-
lar cohort.
Two patients (2/49, 4%) underwent a total of 3 mitral
valve surgeries or catheter-based interventions. One patient
underwent mitral valvotomy; the other underwent mitral val-
votomy followed by mitral valve replacement and died 4
months later. Too few patients underwent mitral valve inter-
vention to analyze for predictors of MV intervention.gery c February 2009
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Palliation strategy P value
Biventricular Univentricular Univariate Multivariate
Total 53 33
Male 35 (66%) 19 (58%) NS NS
PMV type .026 .008
True PMV 25 (47%) 24 (73%)
PLAMV 28 (53%) 9 (27%)
Dominant papillary muscle NS NS
ALPM 15 (28%) 8 (24%)
PMPM 38 (72%) 25 (76%)
Associated lesions
Ventricular septal defect 24 (45%) 20 (61%) .06 NS
Conoventricular 16 (30%) 13 (40%) NS NS
Malalignment 6 (11%) 2 (6%) NS NS
Muscular 4 (8%) 9 (27%) .027 .033
Inlet 0 2 (6%) NS NS
Atrial septal defect 5 (9%) 6 (18%) NS NS
Hypoplastic left ventricle 4 (8%) 25 (76%) <.001 <.001
Aortic stenosis 7 (13%) 14 (42%) .004 NS
Aortic atresia 0 4 (12%) .019 NS
Bicuspid aortic valve 20 (38%) 15 (45%) NS NS
Subaortic stenosis 4 (8%) 8 (24%) .052 NS
Aortic arch hypoplasia 12 (23%) 23 (70%) <.001 NS
Supravalvular mitral ring 4 (8%) 1 (3%) NS NS
Coarctation of aorta 29 (55%) 19 (58%) NS NS
Interrupted aortic arch 2 (4%) 0 NS NS
Tetralogy of Fallot* 6 (11%) 0 NS NS
Double-outlet right ventricle 0 2 (6%) NS NS
Dextrotransposition of great arteries 1 (2%) 0 NS NS
Initial mitral stenosis 16 (30%) 21 (58%) NS NS
Left superior vena cava to coronary sinus 4 (8%) 11 (33%) .003 NS
Left-sided obstructive lesions
0 19 (36%) 2 (15%) NS NS
1 34 (64%) 28 (85%) NS NS
2 17 (32%) 23 (70%) <.001 .002
3 4 (8%) 14 (42%) <.001 NS
Values are numbers of patients with percentages of palliation type with each characteristic. NS, Not significant; PMV, parachute mitral valve; PLAMV, parachutelike asymmetric
mitral valve; ALPM, anterolateral papillary muscle; PMPM, posteromedial papillary muscle. *Tetralogy of Fallot alone, with absent pulmonary valve, or with pulmonary atresia.Biventricular Group Follow-up
Echocardiographic data. Of the 49 patients in the biven-
tricular follow-up group, 1 (2%) had a single echocardiogram
before death and was therefore not included in MS or MR anal-
ysis because progressive MS and progressive MR analysis re-
quired serial echocardiograms. The 48 remaining patients had
a median follow-up of 6.4 years (7 days–17.8 years).
Sixteen (33%) patients had MS at initial echocardiogram
(Figures 2 and E1). The initial median peak gradient in pa-
tients with MS was 14 mm Hg (6–20 mm Hg), with a median
mean gradient of 6 mm Hg (5–13 mm Hg). On the most re-
cent echocardiogram, 22 of the patients in the biventricular
group (46%) had MS. The median peak gradient at fol-
low-up was 15 mm Hg (9–29 mm Hg), with a median
mean gradient of 6 mm Hg (4–14 mmHg). Eleven of the
22 patients (50%) had progressive MS. Although thereThe Journal of Thoracic and Cwas a trend toward progression of MS from initial to most
recent echocardiogram (P¼ .07), 5 of 16 patients with initial
MS had a decrease in level of MS from initial to most recent
echocardiogram. Two of the 5 patients with a decrease in MS
from initial to most recent echocardiogram had undergone
ventricular septal defect closure during the interim period.
Six (13%) of the patients in the biventricular follow-up
group had trivial or mild MR on initial echocardiogram,
and no patients had moderate or severe MR (Figures 2 and
E2). Fourteen patients (29%) had MR noted on the most
recent echocardiogram; 2 of them had hemodynamically sig-
nificant MR. Eleven of the 14 patients (79%) had progres-
sive MR. There was statistically significant progression of
MR from initial to most recent echocardiogram (P ¼ .003).
Predictors of mortality. Within the biventricular cohort,
8 patients (16%) died (Table E2). Three of these 8 patientsardiovascular Surgery c Volume 137, Number 2 389
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and died as a direct result of the consequences of long-stand-
ing moderate or greater MS and pulmonary hypertension.
One of the patients had pulmonary hemorrhage that was
worsened by moderate MS and elevated pulmonary arterial
pressures. Two died of respiratory failure unrelated to the
presence of the PMV. Mortality did not statistically differ
by sex, presence of MS or MR at initial echocardiogram,
or presence of progressive MS or MR at most recent echo-
cardiogram.
Among the 8 patients who died in the biventricular group,
7 patients (88%) had ‘‘true’’ PMV, whereas 1 had PLAMV.
Mortality was associated with having ‘‘true’’ PMV (P ¼
.02) but was not statistically significantly related to a domi-
nant papillary muscle. All 8 patients who died had a ventric-
ular septal defect, and 6 of 8 had a conotruncal anomaly
(tetralogy of Fallot, interrupted aortic arch, aortic arch hypo-
plasia with ventricular septal defect); both malalignment
ventricular septal defect (P ¼ .004) and conotruncal anom-
aly (P< .001) were associated with mortality by univariate
analysis. In addition, surgical repair of ventricular septal de-
fect was associated with mortality (P ¼ .02).
Freedoms from mortality for the entire biventricular co-
hort at 1, 5, and 10 years after initial diagnosis are shown
in Figure 3 (A). The 1-, 5-, and 10-year survivals after strat-
ification by ‘‘true’’ PMV and conotruncal anomalies are
TABLE 3. Surgical and catheter-based interventions by parachute
mitral valve type and dominant papillary muscle anatomy
PMV type
Dominant
papillary muscle
‘‘True’’ PMV PLAMV ALPM PMPM
Total 47 35 23 59
Univentricular group (n ¼ 33) 24 9 8 25
Stage 1 23 (96%) 8 (89%)7 (88%)24 (96%)
Pulmonary arterial band 1 (4%) 1 (11%)1 (12%) 1 (4%)
Biventricular group (n ¼ 53) 25 28 15 38
Ventricular septal defect
repair
10 (40%) 9 (32%)6 (40%)13 (34%)
Atrial septal defect repair 2 (8%) 1 (4%) 2 (13%) 1 (3%)
Pulmonary arterial banding 1 (4%) 0 0 1 (3%)
Aortic arch repair 13 (52%) 18 (64%)7 (47%)24 (63%)
Balloon dilation angioplasty
for recoarctation
2 (8%) 4 (14%)4 (27%) 2 (5%)
Aortic valve procedure* 0 5 (18%)3 (20%) 2 (5%)
Subaortic membrane
resection
0 3 (11%)1 (7%) 2 (5%)
Values are numbers of patients with percentages of parachute mitral valve type or dom-
inant papillary muscle with each intervention, depending on palliation group. Univen-
tricular group interventions listed are only the initial intervention these patients
received; biventricular group interventions listed are all the cardiac interventions these
patients received during the study. There were no significant associations noted be-
tween parachute mitral valve type, dominant papillary muscle, and surgical and cath-
eter-based interventions for the biventricular cohort. PMV, Parachute mitral valve;
PLAMV, parachutelike asymmetric mitral valve; ALPM, anterolateral papillary mus-
cle; PMPM, posteromedial papillary muscle. *Aortic valve procedures included aortic
valvotomy and aortic valvuloplasty.390 The Journal of Thoracic and Cardiovascular Surplotted in Figure 3 (B and C). After stratification, the log-
rank test for the Kaplan–Meier curves was significant for
both ‘‘true’’ PMV (P ¼ .02) and conotruncal anomaly
(P<.001). When Cox proportional hazard regression analysis
was used, only conotruncal anomaly was a significant predic-
tor of mortality (P ¼ .002).
Predictors of MS and MR. Multivariate analysis re-
vealed predictors of MS at initial echocardiogram to include
‘‘true’’ PMV (P ¼ .024). There was no association between
progressive MS and PMV type, dominant papillary muscle,
sex, or any surgical or catheter-based interventions. Because
only 2 patients had hemodynamically significant MR on the
most recent echocardiogram, multivariate modeling for pre-
dictors of progressive MR was not performed.
DISCUSSION
In the past, ‘‘true’’ PMV and PLAMV have been grouped
together under the single anomaly of PMV. This study fur-
ther confirms that PMV is not an isolated cardiac anomaly.
Only 1 patient in the cohort had PMV without an associated
cardiac defect. The most commonly associated cardiac le-
sions on initial echocardiogram were patent ductus arterio-
sus, coarctation of the aorta, and ventricular septal defect.
As in other studies describing the lesions associated with
PMV, left-sided obstructive cardiac lesions and ventricular
septal defects were common in our cohort.3-5,7-8,11-13 There
was no association noted between the number of levels of
obstruction and PMV type. Interestingly, conotruncal anom-
alies accounted for 13% of our PMV cohort. Similarly, Tan-
don and associates13 reported that 26% of the specimens in
a pathologic analysis of 52 cases of PMV had conotruncal
anomalies.
To our knowledge, this is the first study to examine asso-
ciated cardiac lesions by PMV type and dominant papillary
muscle, although no statistically significant associations
were noted. There was no association between PMV type
or dominant papillary muscle and hypoplastic left ventricle,
aortic stenosis or atresia, or subaortic stenosis as single enti-
ties. This may have resulted from the smaller sample size
used for subgroup analyses.
Because ‘‘true’’ PMV and PLAMV are not isolated le-
sions, it is not surprising that the vast majority of patients un-
derwent at least one surgical or catheter-based intervention
separate from the PMV. We believe this to be the first study
to evaluate palliation strategy according to PMV type and
dominant papillary muscle. Univentricular palliation was
elected in 38% of patients. Almost three fourths of the pa-
tients in our study who required univentricular palliation
had ‘‘true’’ PMV. In multivariate analysis, ‘‘true’’ PMV
was associated with univentricular palliation, along with hy-
poplastic left ventricle and the presence of two or more
levels of left-sided obstruction. We speculate that ‘‘true’’
PMV may result in reduced left ventricular inflow relative
to PLAMV and may result in left ventricular hypoplasia,gery c February 2009
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FIGURE 2. Mitral stenosis and mitral regurgitation at initial and most recent echocardiograms in patients with biventricular circulation. Percentages of
patients in biventricular cohort with mitral stenosis and mitral regurgitation at initial and most recent echocardiogram.aortic stenosis, arch hypoplasia, or all three. Excluding
patients in which support was withdrawn, Schaverien and
coworkers8 showed that 13% of their patients underwent
univentricular palliation, but they did not differentiate by
PMV type or dominant papillary muscle.
Among patients who underwent biventricular palliation,
patients with ‘‘true’’ PMV had a greater risk for mortality
than did patients with PLAMV. Mortality in the biventricu-
lar cohort was also associated with conotruncal anomaly. Of
the 8 patients who died in the biventricular group, 6 (75%)
had conotruncal anomaly, and 5 of these 6 had ‘‘true’’ PMV.
This differs considerably from the findings of Oosthoek and
associates,4 whose patients with conotruncal anomaly had
PLAMV almost exclusively. Both the higher incidence of
conotruncal anomaly in Oosthoek and associates’ autopsy
cohort4 and the deaths in our study cohort may potentially
have resulted from right- and left-sided obstructive disease.
Schaverien and coworkers8 found the presence of hypoplas-
tic left ventricle and atrial septal defect to be associated with
mortality in patients with PMV. The mortality analysis per-
formed by Schaverien and coworkers8 included patients
from their PMV cohort both biventricular and univentricular
palliation. Because atrial septal defect and left ventricular
hypoplasia are markers for severe left-sided heart obstruc-
tion, which would likely be associated with univentricular
palliation or higher-risk biventricular palliation, it is not sur-
prising that these markers were associated with death. All
patients in our cohort who had severe left-sided obstruction
underwent univentricular palliation and thus were not in-
cluded in our biventricular mortality analysis.
In our biventricular cohort, we found a significant associ-
ation between ‘‘true’’ PMV and the presence of MS at initial
echocardiogram according to multivariate analysis. Al-
though we found a trend toward progressive MS from initial
to most recent echocardiogram in our study, the analysis was
complicated because the group had both progression andThe Journal of Thoracic and Cregression. In the vast majority of cases in which MS pro-
gressed, MS was not noted at initial echocardiogram.
Among those patients with MS on initial echocardiogram,
most remained at the same level from initial to follow-up
echocardiogram. In the minority of patients in whom the gra-
dient of MS fell from initial to most recent echocardiogram,
ventricular septal defect closure had occurred in the interim,
thereby reducing the preload on the left atrium.
In our study, we found a significant increase in MR from
initial to most recent echocardiogram. Of note, most patients
with progressive MR did not have MR at initial echocardio-
gram, and only a small number of patients had progression to
hemodynamically significant MR. Despite the rarity of
patients with moderate or greater MR at most recent echo-
cardiogram, we believe that patients with PMV may be at
risk for progressive MR and should be followed up long-
term for hemodynamically significant MR.
Only 4% of the patients in our biventricular cohort (2/49)
underwent mitral valve interventions. This incidence is
lower than that reported by Schaverien and coworkers,8
who reported mitral valve intervention in 19% of their co-
hort. This may have been because more patients underwent
univentricular palliation in our cohort, or there may have
been a difference in institutional biases regarding when to
perform mitral valve intervention for MS.
Study Limitations
This study has several potential limitations. It is a retro-
spective study, and therefore information bias may exist.
The follow-up period between first and last echocardiogram
differed between patients and may not have provided the
long-term follow-up required to assess the effects on mortal-
ity of PMV type, dominant papillary muscle, associated
cardiac lesions, multiple levels of left-sided obstruction,
and progressive MS and MR. Because of the prevalence of
ventricular septal defect and patent ductus arteriosus asardiovascular Surgery c Volume 137, Number 2 391
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FIGURE 3. Kaplan–Meier survival curves. Freedoms from mortality for entire biventricular cohort (A), and stratified for parachute mitral valve type (B) and
presence of conotruncal anomaly (C).associated lesions, some patients may have had the gradient
across the mitral valve overestimated as a consequence of an
increased left atrial preload. Additionally, the prevalence of
ventricular septal defect as an associated lesion may have af-
fected the ability to assess reliably obstructive lesions of the
aortic valve or aortic arch in some patients because of left-to-
right shunting at the ventricular level. Because of different
biases toward univentricular and biventricular palliation
strategies among centers, the patients in our biventricular
cohort may differ from other biventricular cohorts at other
centers, where more patients might undergo biventricular
palliation and therefore undergo more frequent mitral valve
interventions. Although all echocardiograms at our institu-
tion were reviewed by a single cardiologist for anatomy
and associated lesions, follow-up data for patients no longer
at our institution were obtained from outside echocardio-
gram reports. Additionally, only 2 echocardiograms per392 The Journal of Thoracic and Cardiovascular Supatient were reviewed, which may have limited the sensitiv-
ity of the progressive MS and MR analyses.
CONCLUSIONS
Both ‘‘true’’ PMV and PLAMV have a broad spectrum of
associated lesions, both of which have PMPM as the dominant
papillary muscle. ‘‘True’’ PMV, hypoplastic left ventricle, and
the presence of two or more left-sided obstructive lesions were
predictors of univentricular palliation in our center, and in
patients with biventricular palliation, ‘‘true’’ PMV and
conotruncal anomalies were associated with mortality. At
midterm follow-up, among patients who underwent biventric-
ular palliation, progressive MS as seen on echocardiogram
was not uncommon, but mitral valve intervention was rare.
MR in this group was progressive but hemodynamically insig-
nificant. Although progressive MS has not been associated
with mitral valve intervention or mortality in our study torgery c February 2009
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C
H
Ddate, progression of MS should be followed carefully in
patients with ‘‘true’’ PMV and PLAMV in this high-risk
population.
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DTABLE E1. Associated noncardiac abnormalities
No. %
22q11 Microdeletion disorders 4 4.7%
9p Syndrome mosaic 1 1.2%
Trisomy 21 mosaic 1 1.2%
Turner mosaic 1 1.2%
Trisomy 18 1 1.2%
Trisomy 8 1 1.2%
Partial trisomy 6 1 1.2%
6q Deletion 1 1.2%
Jobert syndrome 1 1.2%
Goldenhar syndrome 1 1.2%
Noonan syndrome 1 1.2%
Microcephaly 1 1.2%
Dysplastic kidneys 1 1.2%
Duodenal atresia 1 1.2%
Hemorrhagic gastritis 1 1.2%
Malrotation of intestine 1 1.2%393.e3 The Journal of Thoracic and Cardiovascular Surgery c February 2009
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DTABLE E2. Mortality in the biventricular group
Patient
PMV
type
Dominant
PM Original diagnosis Procedures Cause of death
1 PLAMV ALPM TOF TOF repair, PDA ligation Unknown
2 True PMV ALPM Arch hypoplasia, VSD Coarctation repair, VSD repair Pulmonary hypertension
3 True PMV PMPM TOF and PA with MAPCAs Unifocalization, RV–pulmonary artery
conduit, LPA/RPA balloon dilation
angioplasty and stenting, resection of RV
pseudoaneurysm, coil embolization of
collaterals
Pulmonary hemorrhage followed
by cardiac arrest
4 True PMV ALPM MS, VSD VSD repair, mitral valvuloplasty, MVR Pulmonary hypertension
5 True PMV PMPM TOF and PA with confluent
pulmonary arteries
RV to pulmonary artery conduit placement,
VSD closure
Unknown
6 True PMV PMPM Trisomy 18, VSD, ASD,
PDA, dysplastic PV
No procedures Respiratory failure
7 True PMV PMPM IAA Aortic arch repair, PAB (32), debanding,
VSD closure, residual VSD closure, RVOT
reconstruction, arch patch augmentation
for recoarctation, pacemaker for
resynchronization therapy
DCM, cardiac arrest while
awaiting heart transplant
8 True PMV PMPM TOF with absent PV TOF repair with plication of pulmonary
arteries
Respiratory failure
PMV, Parachute mitral valve; PM, papillary muscle; PLAMV, parachutelike asymmetric mitral valve; ALPM, anterolateral papillary muscle; TOF, Tetralogy of Fallot; PDA, patent
ductus arteriosus; VSD, ventricular septal defect; PMPM, posteromedial papillary muscle; PA, pulmonary atresia; MAPCA, major aortopulmonary collateral artery; RV, right ven-
tricle; LPA, left pulmonary artery; RPA, right pulmonary artery;MS,mitral stenosis;MVR, mitral valve replacement; ASD, atrial septal defect; PV, pulmonary valve; IAA, interrupted
aortic arch; PAB, pulmonary arterial banding; RVOT, right ventricular outflow tract; DCM, dilated cardiomyopathy.The Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 2 393.e4
